The Impact of COVID-19 on HIV Treatment and Research: A Call to Action

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2020 Jul 1

PMID 32599783

Citations 72

Authors

Tiffany Chenneville

Kemesha Gabbidon

Patricia Hanson

Cashea Holyfield

Affiliations

Soon will be listed here.

Abstract

The impact of the COVID-19 pandemic is far reaching, with devastating effects on individuals, communities, and societies across the world. People with chronic health conditions may be at greater risk of contracting or experiencing complications from COVID-19. In addition to illness or death for those who contract the virus, the physical distancing required to flatten the curve of new cases is having a negative impact on the economy, the effects of which intersect with mental health and other existing health concerns, thus affecting marginalized communities. Given that HIV also has a disproportionate impact on marginalized communities, COVID-19 is affecting people with HIV (PWH) in unique ways and will continue to have an impact on HIV research and treatment after the COVID-19 crisis passes. Using the biopsychosocial framework to contextualize the impact of COVID-19 on PWH, the purpose of this review article is to: (1) outline the similarities and differences between the COVID-19 and HIV pandemics; (2) describe the current and future impact of COVID-19 on PWH; and (3) outline a call to action for scientists and practitioners to respond to the impact of COVID-19 on HIV prevention and treatment.

Citing Articles

The relationship between health literacy and COVID-19 prevention behaviors among people living with HIV.

Navidi I, Soltani R AIDS Res Ther. 2025; 22(1):12.

PMID: 39915818 PMC: 11800459. DOI: 10.1186/s12981-025-00704-0.

Health behavior and social crisis in the era of COVID-19 in Malawi: A decolonizing approach to a qualitative study.

Lee H, Bauleni E, Maluwa V, Lee S, Mtengezo J, Kamvaunamwali M Nurs Outlook. 2024; 73(1):102317.

PMID: 39581153 PMC: 11810594. DOI: 10.1016/j.outlook.2024.102317.

Co-Designing Digital Health Intervention for Monitoring Medication and Consultation Among Transgender People in Underserved Communities: Collaborative Approach.

Oluokun E, Adedoyin F, Dogan H, Jiang N JMIR Hum Factors. 2024; 11:e45826.

PMID: 39264700 PMC: 11444122. DOI: 10.2196/45826.

The Effects of COVID-19 Pandemic on HIV Service Provision in Ukraine.

Neduzhko O, Kiriazova T, Zeziulin O, Legkostup L, Riabokon S, DeHovitz J J Int Assoc Provid AIDS Care. 2024; 23:23259582241277649.

PMID: 39252523 PMC: 11384520. DOI: 10.1177/23259582241277649.

Impact of COVID-19 on human immunodeficiency virus tests, new diagnoses, and healthcare visits in the Republic of Korea: a retrospective study from 2016 to 2021.

Kim Y, Park E, Jung Y, Kim K, Kim T, Kim H Osong Public Health Res Perspect. 2024; 15(4):340-352.

PMID: 39091166 PMC: 11391373. DOI: 10.24171/j.phrp.2024.0123.

References

Piot P, Russell S, Larson H . Good politics, bad politics: the experience of AIDS. Am J Public Health. 2007; 97(11):1934-6. PMC: 2040384. DOI: 10.2105/AJPH.2007.121418. View

Chinen J, Shearer W . Molecular virology and immunology of HIV infection. J Allergy Clin Immunol. 2002; 110(2):189-98. DOI: 10.1067/mai.2002.126226. View

Engel G . The clinical application of the biopsychosocial model. Am J Psychiatry. 1980; 137(5):535-44. DOI: 10.1176/ajp.137.5.535. View

Blashill A, Perry N, Safren S . Mental health: a focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes. Curr HIV/AIDS Rep. 2011; 8(4):215-22. PMC: 3623665. DOI: 10.1007/s11904-011-0089-1. View

Wang S, Wang Y, Lu Y, Li J, Song Y, Nyamgerelt M . Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine. J Integr Med. 2020; 18(4):275-283. PMC: 7159848. DOI: 10.1016/j.joim.2020.04.001. View

Liu Y, Gayle A, Wilder-Smith A, Rocklov J . The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020; 27(2). PMC: 7074654. DOI: 10.1093/jtm/taaa021. View

Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W . Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020; 12(4). PMC: 7232198. DOI: 10.3390/v12040372. View

Bekalu M, McCloud R, Viswanath K . Association of Social Media Use With Social Well-Being, Positive Mental Health, and Self-Rated Health: Disentangling Routine Use From Emotional Connection to Use. Health Educ Behav. 2019; 46(2_suppl):69-80. DOI: 10.1177/1090198119863768. View

Burack J, Barrett D, Stall R, Chesney M, Ekstrand M, Coates T . Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993; 270(21):2568-73. View

10.

Laurence J . Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?. AIDS Patient Care STDS. 2020; 34(6):247-248. DOI: 10.1089/apc.2020.29005.com. View

11.

Ickovics J, Hamburger M, Vlahov D, Schoenbaum E, Schuman P, Boland R . Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001; 285(11):1466-74. DOI: 10.1001/jama.285.11.1466. View

12.

Orban L, Stein R, Koenig L, Conner L, Rexhouse E, Lewis J . Coping strategies of adolescents living with HIV: disease-specific stressors and responses. AIDS Care. 2010; 22(4):420-30. DOI: 10.1080/09540120903193724. View

13.

Wu E, Metzger D, Lynch K, Douglas S . Association between alcohol use and HIV viral load. J Acquir Immune Defic Syndr. 2011; 56(5):e129-30. PMC: 3082398. DOI: 10.1097/QAI.0b013e31820dc1c8. View

14.

Wijenberg M, Stapert S, Kohler S, Bol Y . Explaining fatigue in multiple sclerosis: cross-validation of a biopsychosocial model. J Behav Med. 2016; 39(5):815-22. DOI: 10.1007/s10865-016-9749-3. View

15.

Ciesla J, Roberts J . Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001; 158(5):725-30. DOI: 10.1176/appi.ajp.158.5.725. View

16.

Rendina H, Weaver L, Millar B, Lopez-Matos J, Parsons J . Psychosocial Well-Being and HIV-Related Immune Health Outcomes among HIV-Positive Older Adults: Support for a Biopsychosocial Model of HIV Stigma and Health. J Int Assoc Provid AIDS Care. 2019; 18:2325958219888462. PMC: 6893929. DOI: 10.1177/2325958219888462. View

17.

Ornell F, Schuch J, Sordi A, Kessler F . "Pandemic fear" and COVID-19: mental health burden and strategies. Braz J Psychiatry. 2020; 42(3):232-235. PMC: 7236170. DOI: 10.1590/1516-4446-2020-0008. View

18.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

19.

Jordan R, Adab P, Cheng K . Covid-19: risk factors for severe disease and death. BMJ. 2020; 368:m1198. DOI: 10.1136/bmj.m1198. View

20.

Hughes A, Campbell L, Graham H, Post F, Chalder T . A Biopsychosocial Approach to HIV Fatigue: A Cross-Sectional and Prospective Analysis to Identify Key Modifiable Factors. Behav Med. 2020; 47(3):205-213. DOI: 10.1080/08964289.2020.1712582. View